Role of Ayurvedic drug â??AYUSH-Aâ?? in the Management of Bronchial Asthma (TamakaShwasa)
- Conditions
- Health Condition 1: J452- Mild intermittent asthma
- Registration Number
- CTRI/2021/06/034446
- Lead Sponsor
- CENTRAL COUNCIL FOR RESEARCH IN AYURVEDIC SCIENCES MINISTRY OF AYUSH GOVERNMENT OF INDIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients of any gender with age between 18 to 60 years.
2.Patients with mild tomoderate stable Bronchial Asthma (TamakaSwasa) (as per GINA
Guidelines 2020 recommendations) and on regular and stable dose of inhaled therapy (medium â?? high dose ICS alone or ICS+LABA) for at least 4 weeks prior to study entry.
3.Patients willing to participate and provide written consent.
1.Patients with H/O acute exacerbation of respiratory symptoms during last four weeks
2.Patients with evidence of malignancy.
3.Chronic obstructive pulmonary disease, pneumonia, lung cancer and other chronic lung diseases
4.Patients under treatment for Pulmonary TB or with a diagnosis of Pulmonary TB.
5.Patients with uncontrolled Diabetes Mellitus assessed by fasting blood sugar or HbA1c >7.5%.
6.Patients with unstable cardiovascular disease.
7.Patients suffering from other major systemic illness necessitating long term drug treatment (eg: Rheumatoid arthritis, Psycho-Neuro-Endocrinal disorders, etc.)
8.Pulmonary emphysema, chronic obstructive pulmonary disease, pulmonary emphysema, pulmonary heart disease, pneumonia, lung cancer and other lung diseases
9.Patients with concurrent serious hepatic disorder or Renal Disorders
10.Active smokers, alcoholics and/or any form of drug abusers
11.H/o hypersensitivity to the trial drug or any of its ingredients.
12.Pregnancy or lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method